Covered recipient · General Payments record
TAYLOR WRIGHT MCLENDON
Allopathic & Osteopathic Physicians Surgery Plastic and Reconstructive Surgery
General Payments · PY2019–2024
$3,343.73
- Reported across 98 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $598.13 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $491.64 | 13 |
| DAVOL INC. | $45.22 | 2 |
| Galderma Laboratories, L.P. | $34.00 | 2 |
| AXOGEN | $27.27 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.18 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105007997 | CMS |
| ABBVIE INC. | $17.93 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105007999 | CMS |
| ABBVIE INC. | $22.49 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008001 | CMS |
| ABBVIE INC. | $15.45 | 05/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008003 | CMS |
| ABBVIE INC. | $33.05 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008005 | CMS |
| ABBVIE INC. | $23.29 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008007 | CMS |
| ABBVIE INC. | $140.54 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008009 | CMS |
| ABBVIE INC. | $16.30 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008011 | CMS |
| ABBVIE INC. | $18.60 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008013 | CMS |
| ABBVIE INC. | $19.41 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008015 | CMS |
| ABBVIE INC. | $135.00 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008017 | CMS |
| ABBVIE INC. | $16.49 | 11/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008019 | CMS |
| ABBVIE INC. | $16.91 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105008021 | CMS |
| AXOGEN | $27.27 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143637999 | CMS |
| Davol Inc. | $15.54 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127649596 | CMS |
| Davol Inc. | $29.68 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127649598 | CMS |
| Galderma Laboratories, L.P. | $15.84 | 08/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315794 | CMS |
| Galderma Laboratories, L.P. | $18.16 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145315796 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.